Ruirui Zhao

发表

Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.

Jingwei Shao, Ruirui Zhao, Tao Li, 2017, Biomaterials.

Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid

Jingwei Shao, L. Jia, Ruirui Zhao, 2020, Asian journal of pharmaceutical sciences.

Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.

Jingwei Shao, Fan Chen, Ruirui Zhao, 2017, Journal of agricultural and food chemistry.

A carrier-free dual-drug nanodelivery system functionalized with aptamer specific targeting HER2-overexpressing cancer cells.

Jingwei Shao, Longyu Han, Ruirui Zhao, 2017, Journal of materials chemistry. B.

Co‐delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy

Jingwei Shao, Xian Chen, Ruirui Zhao, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

A study to evaluate herb-drug interaction underlying mechanisms: an investigation of ginsenosides attenuating the effect of warfarin on cardiovascular diseases.

Yu Lu, Ruirui Zhao, Bingchen Zhang, 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

The effects of ginsenosides on platelet aggregation and vascular intima in the treatment of cardiovascular diseases: from molecular mechanisms to clinical applications.

Ruirui Zhao, Yifan Fang, Jiali Jiang, 2020, Pharmacological research.

Biomimetic polyphenol-coated nanoparticles by Co-assembly of mTOR inhibitor and photosensitizer for synergistic chemo-photothermal therapy.

Ruirui Zhao, Yifan Fang, Bingchen Zhang, 2021, Colloids and surfaces. B, Biointerfaces.

Co-delivery of Sorafenib and CRISPR/Cas9 Based on Targeted Core-Shell Hollow Mesoporous Organosilica Nanoparticles for Synergistic HCC Therapy.

Jingqing Le, Ruirui Zhao, Jiali Jiang, 2020, ACS applied materials & interfaces.

Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy.

Ruirui Zhao, Lulu Fan, Bingchen Zhang, 2018, Molecular pharmaceutics.

Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies.

Jingwei Shao, Ruirui Zhao, Lulu Fan, 2019, Current cancer drug targets.

Self-assembled Amphiphile-based Nanoparticles for the Inhibition of Hepatocellular Carcinoma Metastasis via ICAM-1 Mediated Cell Adhesion.

Jingqing Le, Ruirui Zhao, Yifan Fang, 2020, Acta biomaterialia.

Carrier-free nanodrugs for in vivo NIR bioimaging and chemo-photothermal synergistic therapy.

Jingqing Le, Ruirui Zhao, Bingchen Zhang, 2019, Journal of materials chemistry. B.

Carrier-free nanodrug: a novel strategy of cancer diagnosis and synergistic therapy.

Ruirui Zhao, Yifan Fang, Mingyue Yang, 2019, International journal of pharmaceutics.

Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma.

Jingwei Shao, Rui Huang, Jingqing Le, 2019, European journal of medicinal chemistry.

Efficient CRISPR/Cas9 gene-chemo synergistic cancer therapy via a stimuli-responsive chitosan-based nanocomplex elicits anti-tumorigenic pathway effect

Jingwei Shao, Ruirui Zhao, Jiali Jiang, 2020 .

A Small Molecule Nanodrug by Self-Assembly of Dual Anticancer Drugs and Photosensitizer for Synergistic near-Infrared Cancer Theranostics.

Yan Guo, Guirong Zheng, Jingwei Shao, 2017, ACS applied materials & interfaces.

Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.

Ruirui Zhao, Guirong Zheng, Kai Jiang, 2018, Acta biomaterialia.

A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers-ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy.

Jingwei Shao, Ruirui Zhao, Guirong Zheng, 2018, Nanomedicine : nanotechnology, biology, and medicine.

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma

Ruirui Zhao, Bingchen Zhang, Shijing Yu, 2023, Asian journal of pharmaceutical sciences.

Multifunctional metal-coordinated Co-assembled carrier-free nanoplatform based on dual-drugs for ferroptosis-mediated cocktail therapy of hepatocellular carcinoma growth and metastasis.

Ruirui Zhao, Jing-Wei Shao, Ling Tong, 2024, Journal of colloid and interface science.